患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not recruiting

• Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
• Diabetes;Type 2 Diabetes Mellitus;Diabetes;Type 2 Diabetes Mellitus;Diabetes;Type 2 Diabetes Mellitus
• Algeria, China, Hong Kong, India, Taiwan, Turkey, Ukraine
• 2015-10-16

• Recruiting

• Optimizing hyperglycaemia management in the Acute Medical Unit: investigation of barriers to achieving adequate glucose control in patients with diabetes in the acute medical setting; introduction and evaluation of tools to assist clinicians in prescribing insulin
• diabetes
• Australia
• 2016-08-23

• Authorised

• A multicentre and international trial of a new treatment regimen containing paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin for people with chronic hepatitis C virus genotype 1 infection and recent injection drug use or receiving opioid substitution therapy.
• Chronic hepatitis C virus genotype 1 infection MedDRA version: 19.0 Level: LLT Classification code 10072844 Term: Hepatitis C virus genotype 1a positive System Organ Class: 100000004848 MedDRA version: 19.0 Level: LLT Classification code 10072845 Term: Hepatitis C virus genotype 1b positive System Organ Class: 100000004848 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
• Australia, Canada, France, New Zealand, Norway, Switzerland
• 2016-07-08

• Recruiting

• Biomarker for Hereditary Angioedema Disease Type 1
• C1 Esterase Inhibitor Deficiency;Angio-Oedema of Lips;Angio-Oedema of Tongue;Abdominal Pain;Laryngeal Edema
• Egypt, Georgia, Germany, India
• 2017-01-18

• Not recruiting

• Safer Conception Intervention for HIV-1 Serodiscordant Couples
• HIV Seropositivity;Pregnancy, High-Risk
• Kenya, United States
• 2017-01-12

• Not recruiting

• Efficacy and Bone Safety of Sotagliflozin Dose 1 and Dose 2 Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
• Type 2 Diabetes Mellitus
• Australia, Canada, Korea, Republic of, Mexico, New Zealand, Russian Federation, Taiwan, United States
• 2017-12-21

• Not recruiting

• A Phase 1, Open-Label, Randomised, Two-Way Crossover Study to Assess the Pharmacokinetics, Relative Bioavailability and Food-Effect of a Single Dose of an Immediate Release and Extended Release Formulation of Propagermanium in Healthy Volunteers
• proteinuria;chronic kidney disease
• Australia
• 2017-12-18

• Authorised

• Research study to determine whether an investigational drug, SHP647, is safe and effective long term in the treatment of moderate to severe Ulcerative Colitis or Crohn's Disease (AIDA)
• Ulcerative colitis or Crohn's Disease MedDRA version: 20.1 Level: LLT Classification code 10045365 Term: Ulcerative colitis System Organ Class: 10017947 - Gastrointestinal disorders MedDRA version: 20.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
• Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Colombia, Croatia, Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Lithuania, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Switzerland, Ukraine, United Kingdom, United States
• 2017-10-25

• Recruiting

• Mucopolysaccharidosis I (MPS I) Registry
• Mucopolysaccharidosis I (MPS I)
• Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Czechia, Denmark, France, Hong Kong, India, Italy, Japan, Korea, Republic of, Kuwait, Malaysia, Netherlands, Philippines, Poland, Portugal, Russian Federation, Singapore, Slovakia, Taiwan, Thailand, United Arab Emirates, United Kingdom, United States
• 2005-09-02

• Not recruiting

• A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
• Juvenile Idiopathic Arthritis
• Argentina, Australia, Austria, Belgium, Brazil, China, Czechia, Denmark, France, Germany, Israel, Italy, Japan, Mexico, Russian Federation, Spain, Turkey, United Kingdom
• 2018-12-11

• Recruiting

• The XENERA™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
• Breast Neoplasms
• Australia, Belgium, Canada, France, Germany, Greece, Italy, Portugal, Spain, United States
• 2018-09-03

• Authorised

• The Xenera-1 study tests xentuzumab in combination with everolimus and exemestane in post-menopausal women with hormone receptor positive and HER2-negative breast cancer that has spread
• HR+ / HER2- metastatic breast cancer and non-visceral disease MedDRA version: 20.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
• Australia, Belgium, Canada, France, Germany, Greece, Ireland, Italy, Portugal, Spain, United Kingdom, United States
• 2018-08-06

• Authorised

• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Premixed Insulin on Top of Metformin in Patients With Type 2 Diabetes and ± Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
• Patients with Type 2 Diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agents(OADs) MedDRA version: 20.0 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Algeria, Argentina, Austria, Bulgaria, Czech Republic, Greece, India, Korea, Republic of, Kuwait, Macedonia, the former Yugoslav Republic of, Mexico, Romania, Saudi Arabia, Serbia, Spain, Sweden, Taiwan, Turkey, United Arab Emirates
• 2018-07-30

• Not recruiting

• A phase I/II study of povidone-iodine nasal spray (“Nasodine”) to investigate safety and tolerability in healthy volunteers (Stage 1), and to investigate safety and efficacy in patients with the common cold (Stage 2).
• Common Cold
• Australia
• 2018-07-23

• Authorised

• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Premixed Insulin on Top of Metformin in Patients With Type 2 Diabetes and ± Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
• Patients with Type 2 Diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agents(OADs) MedDRA version: 20.0 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Algeria, Argentina, Austria, Bulgaria, Czech Republic, Greece, India, Korea, Republic of, Kuwait, Macedonia, the former Yugoslav Republic of, Mexico, Romania, Saudi Arabia, Serbia, Spain, Sweden, Taiwan, Turkey, United Arab Emirates
• 2018-06-26

• Recruiting

• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)- Measure Up 1
• Atopic Dermatitis
• Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Canada, China, Colombia, Croatia, Denmark, Estonia, Finland, France, Germany, Italy, Japan, Malaysia, New Zealand, Puerto Rico, Romania, Russian Federation, Switzerland, Turkey, Ukraine, United Kingdom, United States
• 2018-06-14

• Authorised

• An International Study Evaluating the Safety of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS)
• Epidermolysis Bullosa Simplex (EBS) MedDRA version: 20.0 Level: PT Classification code 10014989 Term: Epidermolysis bullosa System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
• Australia, Austria, France, Germany, Israel, Italy, Netherlands, United Kingdom, United States
• 2017-11-29

• Recruiting

• A Randomized Experiment of Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial Aim 1
• Malaria;Febrile Illness
• Kenya
• 2019-01-16

• Not recruiting

• Tissue Plasminogen Activator & Plasminogen Activator Inhibitor Type-1 In Gingival Tissues Of Chronic Periodontitis
• Chronic Periodontitis
• Egypt
• 2019-01-10

• Recruiting

• Effect of Adding Metformin to Insulin Therapy on Pregnancy Outcomes in Women With Uncontrolled Type I Diabetes.
• Type1 Diabetes Mellitus
• Egypt
• 2019-04-20